Solventum Co. (NYSE:SOLV – Get Free Report) has been assigned an average rating of “Hold” from the eleven brokerages that are currently covering the company, MarketBeat.com reports.
Roman's restructuring, which included spinning off 3M's healthcare business as Solventum in 2024, cutting less profitable consumer product lines, reducing management layers, cutting jobs ...
Solventum (NYSE:SOLV – Free Report) had its price target boosted by Bank of America from $80.00 to $85.00 in a research report released on Wednesday,Benzinga reports.Bank of America currently ...
A nervy Nathan Aspinall stumbled through his World Darts Championship opener, edging past Leonard Gates on the same night that Christian Kist hit a nine-darter in defeat. Aspinall, who suffered a ...
Hosted on MSN18d
Solventum: Q4 EPS Beats, Cash Flow DipsDiversified healthcare company Solventum (NYSE:SOLV) reported fourth-quarter 2024 earnings on Thursday, Feb. 27, that topped analysts' consensus estimates. Adjusted EPS for the quarter came in at ...
Shares of healthcare solutions provider Solventum (NYSE:SOLV) fell 6.5% in the morning session after the company reported weak fourth quarter results: its full-year EPS guidance missed. On the other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback